The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.
The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...
The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...
A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by antidepressants and obesity medications.
Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections from dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback